Morgan Stanley’s Gyrodyne GYRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $3.16K | Hold |
426
| – | – | ﹤0.01% | 7238 |
|
|
2025
Q4 | $3.84K | Hold |
426
| – | – | ﹤0.01% | 7115 |
|
|
2025
Q3 | $4.26K | Hold |
426
| – | – | ﹤0.01% | 7132 |
|
|
2025
Q2 | $3.67K | Hold |
426
| – | – | ﹤0.01% | 7110 |
|
|
2025
Q1 | $3.45K | Hold |
426
| – | – | ﹤0.01% | 7075 |
|
|
2024
Q4 | $3.84K | Buy |
426
+1
| +0.2% | +$10 | ﹤0.01% | 7076 |
|
|
2024
Q3 | $3.29K | Sell |
425
-986
| -70% | -$7.87K | ﹤0.01% | 7022 |
|
|
2024
Q2 | $11.1K | Buy |
1,411
+600
| +74% | +$4.76K | ﹤0.01% | 6642 |
|
|
2024
Q1 | $6.54K | Sell |
811
-74,077
| -99% | -$654K | ﹤0.01% | 6825 |
|
|
2023
Q4 | $670K | Buy |
74,888
+74,670
| +34,252% | +$726K | ﹤0.01% | 5494 |
|
|
2023
Q3 | $2.19K | Hold |
218
| – | – | ﹤0.01% | 7111 |
|
|
2023
Q2 | $2.07K | Hold |
218
| – | – | ﹤0.01% | 7187 |
|
|
2023
Q1 | $1.86K | Hold |
218
| – | – | ﹤0.01% | 7249 |
|
|
2022
Q4 | $1.77K | Sell |
218
-600
| -73% | -$5.5K | ﹤0.01% | 7390 |
|
|
2022
Q3 | $7K | Hold |
818
| – | – | ﹤0.01% | 7177 |
|
|
2022
Q2 | $9K | Buy |
818
+38
| +5% | +$478 | ﹤0.01% | 7242 |
|
|
2022
Q1 | $11K | Hold |
780
| – | – | ﹤0.01% | 7374 |
|
|
2021
Q4 | $9K | Hold |
780
| – | – | ﹤0.01% | 7499 |
|
|
2021
Q3 | $10K | Hold |
780
| – | – | ﹤0.01% | 7318 |
|
|
2021
Q2 | $10K | Hold |
780
| – | – | ﹤0.01% | 7232 |
|
|
2021
Q1 | $12K | Hold |
780
| – | – | ﹤0.01% | 6887 |
|
|
2020
Q4 | $13K | Buy |
780
+8
| +1% | +$134 | ﹤0.01% | 6565 |
|
|
2020
Q3 | $13K | Hold |
772
| – | – | ﹤0.01% | 6187 |
|
|
2020
Q2 | $12K | Sell |
772
-4,990
| -87% | -$81K | ﹤0.01% | 6122 |
|
|
2020
Q1 | $84K | Buy |
5,762
+4,990
| +646% | +$89.9K | ﹤0.01% | 5253 |
|
|
2019
Q4 | $15K | Sell |
772
-7,852
| -91% | -$152K | ﹤0.01% | 6170 |
|
|
2019
Q3 | $170K | Buy |
8,624
+7,852
| +1,017% | +$148K | ﹤0.01% | 5219 |
|
|
2019
Q2 | $14K | Hold |
772
| – | – | ﹤0.01% | 6044 |
|
|
2019
Q1 | $14K | Hold |
772
| – | – | ﹤0.01% | 6109 |
|
|
2018
Q4 | $13K | Hold |
772
| – | – | ﹤0.01% | 6111 |
|
|
2018
Q3 | $16K | Hold |
772
| – | – | ﹤0.01% | 6199 |
|
|
2018
Q2 | $16K | Hold |
772
| – | – | ﹤0.01% | 6199 |
|
|
2018
Q1 | $16K | Hold |
772
| – | – | ﹤0.01% | 6171 |
|
|
2017
Q4 | $16K | Buy |
772
+1
| +0.1% | +$21 | ﹤0.01% | 6131 |
|
|
2017
Q3 | $17K | Hold |
771
| – | – | ﹤0.01% | 6056 |
|
|
2017
Q2 | $16K | Hold |
771
| – | – | ﹤0.01% | 6139 |
|
|
2017
Q1 | $16K | Hold |
771
| – | – | ﹤0.01% | 6135 |
|
|
2016
Q4 | $14K | Buy |
771
+132
| +21% | +$2.44K | ﹤0.01% | 6080 |
|
|
2016
Q3 | $12K | Sell |
639
-152
| -19% | -$3.05K | ﹤0.01% | 6072 |
|
|
2016
Q2 | $16K | Hold |
791
| – | – | ﹤0.01% | 5924 |
|
|
2016
Q1 | $21K | Buy |
791
+592
| +297% | +$16.3K | ﹤0.01% | 5903 |
|
|
2015
Q4 | $5K | Sell |
199
-39
| -16% | -$1.05K | ﹤0.01% | 6373 |
|
|
2015
Q3 | $6K | Sell |
238
-3,531
| -94% | -$111K | ﹤0.01% | 6353 |
|
|
2015
Q2 | $126K | Buy |
3,769
+99
| +3% | +$3.84K | ﹤0.01% | 5469 |
|
|
2015
Q1 | $164K | Buy |
3,670
+157
| +4% | +$6.95K | ﹤0.01% | 5297 |
|
|
2014
Q4 | $160K | Sell |
3,513
-16
| -0.5% | -$784 | ﹤0.01% | 5341 |
|
|
2014
Q3 | $196K | Hold |
3,529
| – | – | ﹤0.01% | 5155 |
|
|
2014
Q2 | $201K | Sell |
3,529
-203
| -5% | -$12.1K | ﹤0.01% | 5157 |
|
|
2014
Q1 | $253K | Buy |
3,732
+3,442
| +1,187% | +$263K | ﹤0.01% | 4991 |
|
|
2013
Q4 | $41K | Sell |
290
-80
| -22% | -$64.6K | ﹤0.01% | 5665 |
|
|
2013
Q3 | $308K | Sell |
370
-1,431
| -79% | -$1.14M | ﹤0.01% | 4642 |
|
|
2013
Q2 | $1.43M | Buy |
+1,801
| New | +$1.46M | ﹤0.01% | 3410 |
|
Other funds holding GYRO
TL
GF
GCIA
BI
TA
CL
GI
RHAM
ASN
Morgan Stanley's GYRO Position: Q1 2026 in Review
Morgan Stanley held its Gyrodyne (GYRO) position steady in Q1 2026 at 426 shares worth $3.16K. The position accounts for ﹤0.01% of the portfolio, ranked #7238.
Morgan Stanley first reported a position in GYRO in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.43M in Q2 2013. 13 funds tracked by Wall St. Rank hold GYRO as of Q1 2026.
- Morgan Stanley held 426 shares of Gyrodyne worth $3.16K as of Q1 2026.
- Morgan Stanley left its Gyrodyne share count unchanged in Q1 2026.
- Gyrodyne made up ﹤0.01% of Morgan Stanley's portfolio in Q1 2026, its #7238 holding.
- Morgan Stanley first reported a position in Gyrodyne in Q2 2013 and has held it in 52 quarters since.
- Morgan Stanley's Gyrodyne position peaked at $1.43M in Q2 2013.
- 13 funds tracked by Wall St. Rank held Gyrodyne as of Q1 2026.
Based on Morgan Stanley's 13F filing for Q1 2026, filed 15 May 2026.